These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 33846298
1. HLA-DQB1 6672G>C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry. Konte B, Walters JTR, Rujescu D, Legge SE, Pardiñas AF, Cohen D, Pirmohamed M, Tiihonen J, Hartmann AM, Bogers JP, van der Weide J, van der Weide K, Putkonen A, Repo-Tiihonen E, Hallikainen T, Silva E, Ingimarsson O, Sigurdsson E, Kennedy JL, Sullivan PF, Rietschel M, Breen G, Stefansson H, Stefansson K, Collier DA, O'Donovan MC, Giegling I. Transl Psychiatry; 2021 Apr 12; 11(1):214. PubMed ID: 33846298 [Abstract] [Full Text] [Related]
6. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland. Ingimarsson O, MacCabe JH, Haraldsson M, Jónsdóttir H, Sigurdsson E. BMC Psychiatry; 2016 Dec 12; 16(1):441. PubMed ID: 27955666 [Abstract] [Full Text] [Related]
7. Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine. Girardin FR, Poncet A, Perrier A, Vernaz N, Pletscher M, F Samer C, Lieberman JA, Villard J. Pharmacogenomics J; 2019 Apr 12; 19(2):211-218. PubMed ID: 29298994 [Abstract] [Full Text] [Related]
8. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Atkin K, Kendall F, Gould D, Freeman H, Liberman J, O'Sullivan D. Br J Psychiatry; 1996 Oct 12; 169(4):483-8. PubMed ID: 8894200 [Abstract] [Full Text] [Related]
9. Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis. Athanasiou MC, Dettling M, Cascorbi I, Mosyagin I, Salisbury BA, Pierz KA, Zou W, Whalen H, Malhotra AK, Lencz T, Gerson SL, Kane JM, Reed CR. J Clin Psychiatry; 2011 Apr 12; 72(4):458-63. PubMed ID: 20868635 [Abstract] [Full Text] [Related]
10. Haematological side effects of clozapine: patient characteristics. Miller PR, Cutten AE. N Z Med J; 1997 Apr 11; 110(1041):125-7. PubMed ID: 9140414 [Abstract] [Full Text] [Related]
11. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients. Meged S, Stein D, Sitrota P, Melamed Y, Elizur A, Shmuelian I, Gazit E. Int Clin Psychopharmacol; 1999 Sep 11; 14(5):305-12. PubMed ID: 10529073 [Abstract] [Full Text] [Related]
12. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine. Lau KL, Yim PH. East Asian Arch Psychiatry; 2015 Dec 11; 25(4):164-7. PubMed ID: 26764291 [Abstract] [Full Text] [Related]
13. Genetic risk of clozapine-induced leukopenia and neutropenia: a genome-wide association study. Chen J, Yang P, Zhang Q, Chen R, Wang P, Liu B, Sun W, Jian X, Xiang S, Zhou J, Li N, Wang K, Gao C, Wen Y, Wu C, Zhang J, Zhao Y, Yang Q, Li M, Stewart R, Sun Y, Pan D, Niu Y, Wang Z, Xu Y, Li X, He L, Li Z, Shi Y. Transl Psychiatry; 2021 Jun 03; 11(1):343. PubMed ID: 34083506 [Abstract] [Full Text] [Related]
14. A genome-wide association study in individuals of African ancestry reveals the importance of the Duffy-null genotype in the assessment of clozapine-related neutropenia. Legge SE, Pardiñas AF, Helthuis M, Jansen JA, Jollie K, Knapper S, MacCabe JH, Rujescu D, Collier DA, O'Donovan MC, Owen MJ, Walters JTR. Mol Psychiatry; 2019 Mar 03; 24(3):328-337. PubMed ID: 30647433 [Abstract] [Full Text] [Related]
15. Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis. Verbelen M, Collier DA, Cohen D, MacCabe JH, Lewis CM. Pharmacogenomics J; 2015 Oct 03; 15(5):461-6. PubMed ID: 25732907 [Abstract] [Full Text] [Related]
16. Lithium and clozapine-induced neutropenia/agranulocytosis. Blier P, Slater S, Measham T, Koch M, Wiviott G. Int Clin Psychopharmacol; 1998 May 03; 13(3):137-40. PubMed ID: 9690982 [Abstract] [Full Text] [Related]
17. Clozapine treatment in Australia: a review of haematological monitoring. Copolov DL, Bell WR, Benson WJ, Keks NA, Strazzeri DC, Johnson GF. Med J Aust; 1998 May 18; 168(10):495-7. PubMed ID: 9631674 [Abstract] [Full Text] [Related]
18. Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population. van der Weide K, Loovers H, Pondman K, Bogers J, van der Straaten T, Langemeijer E, Cohen D, Commandeur J, van der Weide J. Pharmacogenomics J; 2017 Oct 18; 17(5):471-478. PubMed ID: 27168101 [Abstract] [Full Text] [Related]
19. Hematological adverse events in clozapine-treated children and adolescents. Gerbino-Rosen G, Roofeh D, Tompkins DA, Feryo D, Nusser L, Kranzler H, Napolitano B, Frederickson A, Henderson I, Rhinewine J, Kumra S. J Am Acad Child Adolesc Psychiatry; 2005 Oct 18; 44(10):1024-31. PubMed ID: 16175107 [Abstract] [Full Text] [Related]